Medical Affairs 2.0: GenAI as the Catalyst for Change in Writing, MedComms, and Field Strategy
Digital and AI were hot topics underpinning many of the conversations at the DIA’s Medical Affairs and Scientific Communications (DIA MASC) forum I attended in March 2025, along with a focus on how we can utilize these tools to achieve impactful, engaging, and scientifically accurate communications that resonate with healthcare providers (HCPs) and patients. Along…...
Read MoreTop Stories
Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks...
Science, AI, and Human Ingenuity Converge to
Today, we're witnessing an unprecedented convergence of...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
Effectiveness of Artificial Intelligence-Powered Translation Tools in Developing Medical Publications: An Assessment of Japanese-to-English Translation
Artificial intelligence (AI)–powered translation tools are gaining attention and acceptance to increase efficiency in medical...
Pharma, Physician, and Patient Pain Points Regarding Clinical Trials
Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?
A majority of patients feel lay summaries for clinical trials are very important and won’t...
Vision 2025: Decoding the Medical Affairs Landscape
Medical Affairs is a critical strategic pillars of pharma. Read how Medical Affairs will evolve...
3 Factors That Will Help Pharma Build Public Trust
Pharma must engage with patients at all levels to build public trust...
Digital Therapeutics and Medical Communications: Are We Ready?
Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...